PIHN News 0.0061 05/30/2014 05:21:11 Polaris Intl Hldgs (PIH

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Polaris Intl Hldgs (PIHN) 0.0061 $PIHN

Polaris International Holdings, Inc. to Release Energy Drink Shot
Marketwire - Wed May 28, 8:06AM CDT
Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) is pleased to announce it has reached an agreement with a Dallas based manufacturer to produce a proprietary energy drink shot product as part of its hemp based nutraceutical supplement line. The energy drink shot will be the 3rd nutraceutical product of the Company to go along with its hemp protein powder and brain health supplements.

Polaris International Holdings, Inc., to Release Brain Health Supplement
Marketwire - Wed May 21, 10:45AM CDT
Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) is pleased to announce that it is releasing a brain health supplement as part of its hemp based nutraceutical supplement line. The Company is set to launch this product in the 4th quarter of 2014 to go along with its hemp protein powder supplements.

Polaris International Holdings, Inc., to Release Brain Health Supplement nt
eTeligis - Wed May 21, 10:30AM CDT
PLANO, TX, United States, via eTeligis Inc., 05/21/2014 - - Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) is pleased to announce that it is releasing a brain health supplement as part of its hemp based nutraceutical supplement line.The Company is set to launch this product in the 4th quarter of 2014 to go along with its hemp protein powder supplements.

Polaris International Holdings, Inc. to Launch Nutraceutical Line of Products
Marketwire - Fri May 16, 8:15AM CDT
Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) will be launching a new hemp-based nutraceutical supplement line in the Fall of 2014. The Company's first product will be a new proprietary blend hemp protein powder. The initial flavors of the product will be chocolate, vanilla, and strawberry.

Polaris International Holdings, Inc. Sets Date to Plant Hemp Seed on Kentucky Farm
Marketwire - Thu May 01, 7:15AM CDT
Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) has purchased over 2,000 lbs of hemp seed to plant on the 70 acre farm in Kentucky. The Company plans on planting the seeds on May 24 and 25, 2014, with the help of several area Military Veterans. This event should receive significant media coverage throughout the area.

Cannabis Sector Appears To Stabilize With New Advancements - Company Enters JV for 70 Acre Hemp Farm
PR Newswire - Tue Apr 22, 8:02AM CDT
Marijuana companies acquire resources with expansion in sight: Polaris International Holdings, Inc. (OTC: PIHN), Tranzbyte Corporation (OTC: ERBB), Planda (OTC: PLPL), Nuvilex, Inc. (OTC: NVLX), Latteno Food Corp. (OTC: LATF) and MediSwipe, Inc. (OTC: MWIP)

Polaris International Holdings Enters Joint Venture for Kentucky Hemp Project
PR Newswire - Tue Apr 22, 7:00AM CDT
Polaris International Holdings, Inc. (OTC: PIHN) has entered into a revolutionary agreement with a 70 acre hemp farm in Kentucky. The agreement provides for Polaris to secure 100% of the harvested material for the extraction of cannabinoids.

PIHN Plans for Rapid Expansion With New Sales Offices in Florida, Canada and Mexico
Marketwire - Wed Apr 09, 6:20AM CDT
Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) is excited to announce its medical division, ProCannas, is opening three new sales offices in Tampa, FL; Vancouver, British Columbia, Canada; and Mexico City, Mexico in the Summer of 2014. The Company is also exploring the possibility of distribution channels in select areas throughout India and Asia.

PIHN Announces Procannas' Cannabinoid Transdermal Product Development
Marketwire - Mon Apr 07, 6:15AM CDT
Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) is excited to announce its medical division, ProCannas, has begun development of a unique and proprietary transdermal patch capable of delivering cannabinoids directly through the skin. This hallmark solution is intended to address a significant, unmet need for individuals requiring long-term, time released delivery. The Company believes, subject to testing and trials to be initiated by our participating physicians, that the patch may able to deliver cannabinoids for up to 48 hours. The Company further expects that this mechanism of delivery could revolutionize the way cannabinoids are introduced into the blood stream minimizing the negative effects on lungs and other organs commonly seen in other delivery methods. The Company expects to be ready to begin trials in 90 days.

PIHN Hires New Medical Director to Start International Clinical Trials
Marketwire - Tue Apr 01, 5:45AM CDT
Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) is pleased to announce the Company has added Dr. Vasthi Alvarez Avila as Medical Director and to the Corporate Board of Directors. Dr. Alvarez Avila graduated from Universidad De Montemorelos in Mexico. She has 8 years of medical service in Family Practice and General Surgery throughout Mexico.

Polaris International Holdings Signs Agreement With India Based Affiliates and Secures New Offices
Marketwire - Thu Mar 20, 7:46AM CDT
Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) is pleased to announce that it has completed an important agreement with GBISS, Inc. and its India based affiliates to begin project management and manufacturing of the Company's exclusive Procannas(R) Cannatrol pharmaceutical grade core ingredients and sub-formulations.

PIHN Signs Exclusive Rights to ProCannas(R) Cannabinoid Line
Marketwire - Wed Mar 19, 6:15AM CDT
Polaris International Holdings, Inc. (PINKSHEETS: PIHN) (OTC Pink: PIHN) is pleased to announce they have entered into an exclusive agreement with Longevity Holdings, LLC for the ProCannas(R) product line. The agreement grants the sole rights to sell, distribute and market the provisional patent-pending formulation of Longevity Holding, LLC cannabis oil. The ProCannas(R) line is unique due to the blend of cannabinoids, vitamins, antioxidants, and other proven ingredients to be used for medicinal purposes. The full ProCannas(R) Line will include liquid drops for ingestion, tablets, and transdermal patches. The oils used in these formulations are high quality pharmaceutical grade and will only be available through licensed participating physicians.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Human Frontier Mission Puts AI Research on Display

Updated Category News Views 45

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 182

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
Domino's Probe Puts Franchise Disclosure Under Lens

Updated Category News Views 121

A franchisee's shuttered stores can turn cheerful unit-growth talk into a nasty accounting of credibility, and that is the uncomfortable territory Domino's now occupies. Kahn Swick & Foti has opened an investigation into whether Domino's officers and directors breached fiduciary duties or violated state or federal law. That is not a finding of misconduct. It is a legal...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 93

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
California Rideshare Data Exposes an Insurance Gap

Updated Category News Views 52

Three California counties carried an outsized share of rideshare traffic, and the insurance fine print is where this story gets uncomfortable. A review by Mendez & Sanchez says Los Angeles, San Francisco, and San Diego counties accounted for nearly two-thirds of statewide rideshare trips between September 2019 and August 2020. That is an old snapshot, sure, but it points...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 105

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 104

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
AMD Faces Fresh Scrutiny Over China Supply Exposure

Updated Category News Views 140

One nasty report can turn a chip giant’s supply chain into a flashing red light, and that is precisely the mess confronting Advanced Micro Devices investors this week. Shares fell more than 7.7% on November 19 after Hunterbrook Media published allegations involving China-linked sales, firmware and manufacturing relationships. Then, on November 20, shareholder-rights...

Continue Reading
California Initiative Puts Missed Diagnoses in Focus

Updated Category News Views 98

When Reassurance Turns Into a Risk A clean scan can become a dangerous lullaby when symptoms refuse to leave. That is the hard, unsettling territory behind Hodes Milman’s new Missed Diagnosis Project: California, launched November 20, 2026. The statewide effort focuses on breast cancer diagnostic failures: scans read as benign when more scrutiny was warranted, referrals...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 97

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading

Top 5 Most Recently Viewed Articles

Stellantis NV: Short Interest Shift Sparks Investor Sentiment Questions

Updated Category News Views 299

Stellantis NV's (NYSE:STLA) short interest saw a notable drop of 13.81% since its last report, now standing at 44.96 million shares sold short, or about 1.56% of all tradable shares. Sounds like good news, right? But hang on—this isn't just a free pass to pop the champagne. When we talk short interest, we're peeling back layers on market sentiment that can turn on a...

Continue Reading
Minerals Technologies Showcases Innovative PFAS Solutions at Symposium

Updated Category News Views 185

Minerals Technologies to Present at Gabelli Funds PFAS Symposium Minerals Technologies Inc. (MTI) is thrilled to announce its participation in the upcoming PFAS Symposium hosted by Gabelli Funds. This notable event is set to take place in New York City, bringing together key figures in the industry to discuss significant advancements and novel strategies for tackling...

Continue Reading
Morning Market Insights for Key Stocks: A Daily Review

Updated Category News Views 338

Daily Market Insights: Leading Stocks to Watch Good morning, traders. Today’s notes zero in on SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA—names that tend to steer the broader tape. Our read on price comes from a blend of key levels shaped by price action, trading volume, and options flow. We refresh these levels daily and share them with Market Clubhouse...

Continue Reading
Exploring the Evolving Landscape of Electric Vehicles in the U.S.

Updated Category News Views 224

The Current State of Electric Vehicles in the U.S. The electric vehicle (EV) landscape in the U.S. is experiencing transformative changes. As the country marks significant milestones in EV deployment, there are noteworthy gaps in infrastructure and consumer attitudes that need addressing. The third annual HERE-SBD EV Index reveals how far the U.S. has come, yet highlights...

Continue Reading
eBay's Legal Victory: Dismissal of Harmful Product Claims

Updated Category News Views 173

eBay's legal drama hit the news when the U.S. government slammed them with a lawsuit accusing the online giant of violating the Clean Air Act back in 2024. The crux? Selling products that supposedly helped folks skirt around those pesky auto pollution controls. You know how it is—desks buzzing about regulatory risks, and traders getting twitchy over such moves. The...

Continue Reading